食管癌碳离子放疗的分次内剂量变化与束流配置
本研究在4例食管癌患者中勾画不同器官定位的boost体积,基于自由呼吸CT设计13种束流几何的碳离子放疗计划,并在代表呼吸周期7个时相的4D-CT上正向计算。基线计划靶区覆盖充足(双束V95>98%,单束>94%),但4D-CT计划降至50-95%;呼吸周期中射程偏差可致脊髓最大剂量高达预期的3.5倍。每例患者至少存在一种束流配置可获得合适计划质量。
要点
- 基线碳离子计划靶区覆盖良好,但4D-CT计划V95降至50-95%。
- 呼吸周期射程偏差可使脊髓最大剂量达预期的3.5倍。
- 每例患者至少有一种束流配置可获得合适计划质量。
核心结论
- 尽管存在分次内运动,食管癌碳离子放疗在根据肿瘤大小和定位选择个体化优化束流配置时,可获得稳健的治疗计划。
研究设计与样本
- 在4例食管癌患者中,于不同器官定位勾画食管boost体积,基于自由呼吸CT计算13种不同束流几何的碳离子放疗计划。
- 在代表呼吸周期7个不同时相的4D-CT数据集上对这些计划进行正向计算,并评估每例患者和每种束流配置的计划质量。
主要发现
- 基线碳离子计划中所有设置的靶区覆盖均充足,双束几何V95>98%,单束几何V95>94%。
- 4D-CT计划中靶区覆盖降低,V95范围为50-95%。
- 危及器官保护充足,但呼吸周期中的射程偏差部分导致脊髓最大剂量高达预期的3.5倍。
- 每例患者至少存在一种束流配置具有合适的计划质量。
关键数值与推荐
- 基线碳离子计划靶区覆盖:双束几何V95>98%,单束几何V95>94%。
- 4D-CT计划靶区覆盖:V95范围50-95%。
- 呼吸周期中脊髓最大剂量可达预期的3.5倍。
临床怎么用
- 食管癌碳离子放疗应基于肿瘤大小和定位选择个体化优化的束流配置。
- 制定计划时需考虑分次内运动导致的射程偏差对脊髓剂量的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In carbon ion radiotherapy (CIR) for esophageal cancer, organ and target motion is a major challenge for treatment planning due to potential range deviations. This study intends to analyze the impact of intrafractional variations on dosimetric parameters and to identify favourable settings for robust treatment plans. METHODS: We contoured esophageal boost volumes in different organ localizations for four patients and calculated CIR-plans with 13 different beam geometries on a free-breathing CT. Forward calculation of these plans was performed on 4D-CT datasets representing seven different phases of the breathing cycle. Plan quality was assessed for each patient and beam configuration. RESULTS: Target volume coverage was adequate for all settings in the baseline CIR-plans (V95 > 98% for two-beam geometries, > 94% for one-beam geometries), but reduced on 4D-CT plans (V95 range 50-95%). Sparing of the organs at risk (OAR) was adequate, but range deviations during the breathing cycle partly caused critical, maximum doses to spinal cord up to 3.5x higher than expected. There was at least one beam configuration for each patient with appropriate plan quality. CONCLUSIONS: Despite intrafractional motion, CIR for esophageal cancer is possible with robust treatment plans when an individually optimized beam setup is selected depending on tumor size and localization.
引用
- Haefner MF, Sterzing F, Krug D, et al. Intrafractional dose variation and beam configuration in carbon ion radiotherapy for esophageal cancer. Radiat Oncol. 2016. PMID: 27846916
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。